Ealing Southall MP Virendra Sharma backs call for 50 year forward view for NHS….reports Asian Lite News
Ealing Southall MP Virendra Sharma is backing a call for the NHS to put in place measures needed to deliver innovative and effective treatments that will improve patient outcomes for the next 50 years.
As part of this year’s Medical Technology Week, Virendra Sharma attended an event at the House of Commons organised by the Medical Technology Group, a coalition of patient groups, research charities and medical device manufacturers, which is committed to increasing patient access to high quality, life-improving medical technologies to all who need it.
He heard how medical technology has changed over the past 50 years, how it has improved the lives of patients, and about the MTG’s call for a ‘NHS 50 Year Forward View’. With the NHS under increasing pressure to meet its budget targets, the MTG is highlighting the role that medical technologies – anything from an insulin pump to a hip joint replacement – can play in improving treatments and achieving cost savings.
“It’s clear that medical technology could be used more to improve the lives of patients’ with a range of conditions, helping them return to work, care for loved ones or just enabling them to be looked after at home,” said Mr Sharma. “Medical technology can also save the NHS money in the long term by reducing hospital admissions and avoiding complications. But access to these technologies is not always possible, that’s why I’m calling on the NHS to take a long term view on the benefits.”
Barbara Harpham, chair of the Medical Technology Group, says: “The NHS is not adopting medical technologies as widely and as quickly as it should, and patients in the UK are missing out when compared to other countries.
“Insulin pumps are a prime example. These have been approved by NICE for the treatment of Type 1 diabetes, but uptake in the UK is currently 6%, half the target 12% recommended by NICE in 2008.
“We also rank 21st in Western Europe, behind countries like Greece, Slovakia and Malta, for implant rates of ICDs (implantable cardioverter defibrillators), which have an overwhelmingly positive clinical record for preventing deaths and hospital admissions for heart failure patients.
“We are calling on the NHS to address the disparities in medical technology access and ensure that when decisions are made, they are based on the value the technology delivers to patients and to the NHS over the long term.”
The Medical Technology Group (MTG) is a coalition of patient groups, research charities and medical device manufacturers working to make medical technologies available to everyone who needs them. Uptake of medical technology in the UK is not as good as it should be, given its great potential to provide value for money to the NHS, patients and taxpayers. The MTG believes that patients and clinicians need better information about medical technologies so that they can make informed choices about their medical care.